LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
LEPU BIO-B: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETINGHELD ON JUNE 19, 2024
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
LEPU BIO-B: Proxy Form for the Annual General Meeting to be held on June 19 2024
LEPU BIO-B: (1) 2023 REPORT OF THE BOARD OF DIRECTORS(2) 2023 REPORT OF THE BOARD OF SUPERVISORS(3) 2023 ANNUAL REPORT(4) 2023 FINANCIAL ACCOUNTS REPORT(5) 2024 FINANCIAL BUDGET(6) 2023 ANNUAL PROFIT DISTRIBUTION PLAN(7) RE-APPOINTMENT OF AUDITOR(8) GENERAL MAN
LEPU BIO-B: NOTICE OF THE 2023 ANNUAL GENERAL MEETING
LEPU BIO-B: Next Day Disclosure Return
LEPU BIO-B: COMPLETION OF PLACING OF NEW H SHARES UNDER GENERALMANDATE
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTTHREE CLINICAL TRIAL RESULTSPRESENTED AT 2024 ASCO ANNUAL MEETING
LEPU BIO-B: Placing of New H Shares under General Mandate
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
LEPU BIO-B: 2023 Annual Report
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTUPDATE ON THE LICENSE AGREEMENT WITHASTRAZENECA FOR CMG901
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
LEPU BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2023
LEPU BIO-B: NOTICE OF BOARD MEETING
LEPU BIO-B: VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG004A FOR THE TREATMENT OF PANCREATIC CANCER
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
LEPU BIO-B: ARTICLES OF ASSOCIATION
No Data